FRI163 Central Role Of Mirnas During Kidney Development And Establishment Of The Mineralocorticoid Signaling Pathway Establishment Of The Mineralocorticoid Signaling Pathway
Authors: Hani Imene , An Vu Thi , Brillet Riwan , Perrot Julie , Bouligand Jérôme , Guegan Justine , Cherradi Nadia , Kamenicky Peter , Lombes Marc , Martinerie Laetitia , Viengchareun Say 
Published: October 2023

Disclosure: I. Hani: None. T. Vu: None. R. Brillet: None. J. Perrot: None. J. Bouligand: None. J. Guegan: None. N. Cherradi: None. P. Kamenicky: None. M. Lombes: None. L. Martinerie: None. S. Viengchareun: None.

In tight epithelia, aldosterone controls sodium and water homeostasis by binding to the Mineralocorticoid Receptor (MR), a steroid nuclear receptor. We have identified a specific temporal window during renal development in which the mineralocorticoid signaling pathway is ineffective due to downregulation of MR expression, explaining physiological sodium wasting observed in human newborns during first days of life. However, underlying molecular mechanisms controlling MR expression remain unknown. Recently, we demonstrated in adult renal KC3AC1 cell line that MR expression is controlled by microRNAs (miR-30c-2-3p and miR-324-5p) in response to variations of tonicity. These regulators bind to 3'-untranslated region (3'-UTR) of MR transcripts to modulate their stability and translation. Therefore, we hypothesized that these miRNAs may be responsible for low expression level of MR at birth, where variations in tonicity are observed due to the transition from intra-amniotic to extra-uterine life. Using primary cultures of renal epithelial cells from neonatal mouse kidneys, harvested at birth (D0) and at Day 8 postnatal (D8), we showed that only miR-30c-2-3p regulates MR expression at D8. For this reason, we performed a complete transcriptomic analysis (miRNA-Seq and RNA-Seq) of kidneys collected at D0 and D8 to identify other miRNAs specifically involved in regulation of MR expression in perinatal period. Bioinformatics analysis allowed us to identify deregulated miRNAs and transcripts between D0 and D8 and to specify their involvement in biological processes and/or signaling pathways. We mainly focused on deregulated miRNAs that may modulate MR expression and affect mineralocorticoid signaling. miR-Seq identified 221 differentially expressed miRNAs. First, we selected 3 over- (miR-431-5p, miR-409-3p, and miR-92a-1-5p) and 3 under-expressed (miR-30a-5p, miR-30e-5p, and miR-802-5p) candidate miRNAs (FDR&lt;0.05 and log2FC&gt;1) having putative binding sites in MR 3'-UTR. Paradoxically, we showed in primary kidney cultures that overexpression of miR-30a-5p, miR-30e-5p, or miR-802-5p increased MR expression (from 50 to 100%, P&lt;0.05) at D0, suggesting that these miRNAs may either positively modulate MR expression or may involve an intermediate regulator. On the opposite, over-expression of miR-92a-1-5p, miR-431-5p, and miR-409-3p at D8 led to a decrease (from 30-40%, P&lt;0.05) in MR expression, suggesting that these miRNAs may modulate MR expression in postnatal period. Currently, we are evaluating whether they could be used as prognostic or severity biomarkers of water loss in neonates by quantifying these candidate miRNAs in urine exosomes of preterm and term infants. A better understanding of mechanisms regulating MR expression in the perinatal period will undoubtedly have a major impact on the management of premature infants with sodium balance maladjustment at birth.

Presentation Date: Friday, June 16, 2023